tomeko

Fibrosis, neurodegeneration, and cerebral angiomatosis

Just diagnosed with Fibrosis, neurodegeneration, and cerebral angiomatosis?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Fibrosis, neurodegeneration, and cerebral angiomatosis, look for clinical trials, and connect with others living with it — all in one place.

Open the full Fibrosis, neurodegeneration, and cerebral angiomatosis hub →

Overview

Fibrosis, neurodegeneration, and cerebral angiomatosis is a rare condition. Also known as FINCA, Interstitial lung fibrosis-neurodegeneration-cerebral angiomatosis syndrome. Tomeko brings together the specialists, research, clinical trials, treatments and community for Fibrosis, neurodegeneration, and cerebral angiomatosis so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:621758 · OMIM 618278 · ICD-10 G31.8 · GARD 0027940

Find care for Fibrosis, neurodegeneration, and cerebral angiomatosis

Authoritative references for Fibrosis, neurodegeneration, and cerebral angiomatosis

Common questions

I was just diagnosed with Fibrosis, neurodegeneration, and cerebral angiomatosis — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Fibrosis, neurodegeneration, and cerebral angiomatosis, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Fibrosis, neurodegeneration, and cerebral angiomatosis?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Fibrosis, neurodegeneration, and cerebral angiomatosis, filtered to your area.

Are there clinical trials for Fibrosis, neurodegeneration, and cerebral angiomatosis?

Tomeko shows live, recruiting studies for Fibrosis, neurodegeneration, and cerebral angiomatosis from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com